These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 33822548)

  • 1. [The use of intralaboratory and external quality control of immunohistochemical studies to improve the detection of estrogen and progesterone receptors].
    Kushnarev VA; Kudaibergenova AG; Zavalishina LE
    Arkh Patol; 2021; 83(3):5-9. PubMed ID: 33822548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External quality assessment (EQA) program for the immunohistochemical detection of ER, PR and Ki-67 in breast cancer: results of an interlaboratory reproducibility ring study in China.
    Pu T; Shui R; Shi J; Liang Z; Yang W; Bu H; Li Q; Zhang Z;
    BMC Cancer; 2019 Oct; 19(1):978. PubMed ID: 31640622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical demonstration of oestrogen and progesterone receptors: correlation of standards achieved on in house tumours with that achieved on external quality assessment material in over 150 laboratories from 26 countries.
    Rhodes A; Jasani B; Balaton AJ; Miller KD
    J Clin Pathol; 2000 Apr; 53(4):292-301. PubMed ID: 10823126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an evidence-based approach to external quality assurance for breast cancer hormone receptor immunohistochemistry: comparison of reference values.
    Makretsov N; Gilks CB; Alaghehbandan R; Garratt J; Quenneville L; Mercer J; Palavdzic D; Torlakovic EE; ;
    Arch Pathol Lab Med; 2011 Jul; 135(7):874-81. PubMed ID: 21732777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the PharmDx immunohistochemical system with standard methods for assessing estrogen and progesterone receptors in invasive carcinoma of the breast.
    Gill MS; Paish EC; Ronan J; Green AR; Ellis IO; Lee AH
    Appl Immunohistochem Mol Morphol; 2013 Jan; 21(1):90-3. PubMed ID: 22820666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of estrogen and progesterone receptors in breast cancers with monoclonal antibodies. Different results with enzyme-immunoassay and immunohistochemical methods.
    Mink D; Hollaender M; von Tongelen B; Villena-Heinsen C; Schmidt W
    Eur J Gynaecol Oncol; 1995; 16(2):81-91. PubMed ID: 7641743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical detection of estrogen and progesterone receptors in primary breast cancer.
    Chariyalertsak S; Chariyalertsak S; Ruangvejvorachi P
    Asian Pac J Allergy Immunol; 1998 Dec; 16(4):161-6. PubMed ID: 10219897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical detection of sex steroid receptors in breast cancer using routine paraffin sections: comparison with frozen sections and enzyme immunoassay.
    Elias JM; Margiotta M; Sexton TR; Heimann A
    J Cell Biochem Suppl; 1994; 19():126-33. PubMed ID: 7823584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers.
    Nadji M; Gomez-Fernandez C; Ganjei-Azar P; Morales AR
    Am J Clin Pathol; 2005 Jan; 123(1):21-7. PubMed ID: 15762276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of estrogen and progesterone receptor and neu expression in breast carcinoma.
    Chu JS; Lee WJ; Chen KM; Hsu HC
    J Formos Med Assoc; 1994 Apr; 93(4):277-82. PubMed ID: 7914767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concordance between semiquantitative immunohistochemical assay and oncotype DX RT-PCR assay for estrogen and progesterone receptors.
    O'Connor SM; Beriwal S; Dabbs DJ; Bhargava R
    Appl Immunohistochem Mol Morphol; 2010 May; 18(3):268-72. PubMed ID: 20186046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological and immunohistochemical study of estrogen and progesterone receptors in normal human breast tissue in adult age groups vulnerable to malignancy.
    Goyal R; Gupta T; Gupta R; Aggarwal A; Sahni D; Singh G
    Clin Anat; 2016 Sep; 29(6):729-37. PubMed ID: 27038435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunohistochemical characteristics of mammary carcinomas with estrogen-negative and progesterone-positive receptors].
    Sundblad AS; Caprarulo L
    Medicina (B Aires); 1996; 56(6):683-9. PubMed ID: 9284572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical determination of estrogen and progesterone receptors in breast cancer: relationship with clinicopathologic factors in 302 patients in Ivory Coast.
    Effi AB; Aman NA; Koui BS; Koffi KD; Traoré ZC; Kouyate M
    BMC Cancer; 2017 Feb; 17(1):115. PubMed ID: 28173783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human breast cancer embedded in paraffin, fixed in Bouin's fluid. Immunohistochemical analysis of estrogen and progesterone receptors].
    Jacquemier J; Boudaoura T; Martin PM; Torrente M; Hassoun J
    Ann Pathol; 1991; 11(4):224-30. PubMed ID: 1958256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone receptors in breast cancer: more than estrogen receptors.
    Lamb CA; Vanzulli SI; Lanari C
    Medicina (B Aires); 2019; 79(Spec 6/1):540-545. PubMed ID: 31864223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of different antibodies for detection of progesterone receptor in breast cancer.
    Press M; Spaulding B; Groshen S; Kaminsky D; Hagerty M; Sherman L; Christensen K; Edwards DP
    Steroids; 2002 Aug; 67(9):799-813. PubMed ID: 12123792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human breast tumors: a comparison between the biochemical method of measuring estrogen and progesterone receptors and that of an immunohistochemical method.
    Lacombe MJ; Delarue JC; Mouriesse H; Contesso G; Friedman S; Sancho-Garnier H; Travagli JP; May-Levin F
    Gynecol Oncol; 1989 Feb; 32(2):174-9. PubMed ID: 2910778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-Appraisal of Estrogen Receptor Negative/Progesterone Receptor Positive (ER-/PR+) Breast Cancer Phenotype: True Subtype or Technical Artefact?
    Foley NM; Coll JM; Lowery AJ; Hynes SO; Kerin MJ; Sheehan M; Brodie C; Sweeney KJ
    Pathol Oncol Res; 2018 Oct; 24(4):881-884. PubMed ID: 28891017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ER-negative /PR-positive breast carcinomas or technical artifacts in immunohistochemistry?
    Maleki Z; Shariat S; Mokri M; Atri M
    Arch Iran Med; 2012 Jun; 15(6):366-9. PubMed ID: 22642247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.